American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Shah
    Shah
  3. Landau
    Landau
  4. Scordo
    Scordo
  5. Hassoun
    Hassoun
  6. Hultcrantz
    Hultcrantz
  7. Lesokhin
    Lesokhin
  8. Mailankody
    Mailankody
  9. Korde
    Korde
  10. Shah
    Shah

Groups

  1. Department of Medicine (56)
  2. Hematologic Malignancies, Division of (56)
  3. Center for Hematologic Malignancies (55)
  4. Bone Marrow Transplant (52)
  5. Survivorship Research (52)
  6. Hematology-Oncology Fellows (50)
  7. CTCR Scholars (46)
  8. Hematologic Malignancies Research (42)
  9. Sloan Kettering Institute Postdocs (41)
  10. Myeloma (38)
Search Within
  1. "Oscar Lahoud"
Formats
  1. Meeting Abstract (46)
  2. Journal Article (9)
  3. Research Letter (1)
Groups
  1. Department of Medicine (56)
  2. Hematologic Malignancies, Division of (56)
  3. Center for Hematologic Malignancies (55)
  4. Bone Marrow Transplant (52)
  5. Survivorship Research (52)
  6. Hematology-Oncology Fellows (50)

More Groups

People
  1. Oscar Lahoud (56)
  2. Sergio Giralt (45)
  3. Gunjan Shah (44)
  4. Heather Landau (42)
  5. Michael Scordo (41)
  6. Hani Hassoun (38)

More People

Years
  1. 2024 (7)
  2. 2023 (18)
  3. 2022 (9)
  4. 2021 (3)
  5. 2020 (7)
  6. 2019 (7)

More Years

Publications
  1. Blood (47)
  2. Blood Advances (9)

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Body mass index trajectory during triplet induction therapy: Clinical implications in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R. S.; Derkach, A.; Furberg, H.; Shekarkhand, T.; Rueda, C.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies
    Journal Article

    Howard, A. J.; Concepcion, I.; Wang, A. X.; Hamadeh, I. S.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Korde, N.; Lesokhin, A. M.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
    Journal Article

    Firestone, R. S.; Socci, N. D.; Shekarkhand, T.; Zhu, M.; Qin, W. G.; Hultcrantz, M.; Mailankody, S.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Journal Article

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M. L.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naìˆve multiple myeloma
    Journal Article

    Firestone, R. S.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Qin, W. G.; Patel, D.; Tan, C. R.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Longitudinal assessment of minimal residual disease (MRD) in the ATLAS randomized phase 3 trial of post-transplant treatment with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide (R) alone in patients with newly diagnosed multiple myeloma (NDMM)
    Meeting Abstract

    Kubicki, T.; Dytfeld, D.; Wrobel, T.; Jamroziak, K.; Robak, P.; Czyz, J.; Tyczynska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Nowicki, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Artificial intelligence enabled ECG interpretation informs outcomes after autologous transplantation for multiple myeloma
    Meeting Abstract

    Shaffer, B. C.; Attia, I. Z.; Greason, G.; Chinapen, S.; Brown, S.; Chung, D.; Lahoud, O. B.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save